Important Safety Information | Prescribing and Patient Information | email iconE-mail this page to a friend
Aricpet 23 mg logo

Aricept® 23 mg is now FDA approved for moderate to severe Alzheimer’s.

Ask the doctor about new ARICEPT 23 mg tablets for your loved one

Important Safety Information

  • ARICEPT® (donepezil HCl) may not be for everyone. People at risk for stomach ulcers or who take certain other medicines should tell their doctors because serious stomach problems, such as bleeding, may get worse.
  • People at risk for certain heart conditions should tell their doctor before starting ARICEPT because they may experience fainting. People with serious lung conditions and difficulty breathing, bladder problems or seizures should tell their doctor before using ARICEPT. ARICEPT 23 mg/day is associated with weight loss. Check with the doctor if this is a concern. Inform the doctor if the patient needs surgery requiring anesthesia while taking ARICEPT.
  • Some people may have nausea, diarrhea, difficulty sleeping, vomiting or muscle cramps. Incidence of nausea and vomiting were markedly greater in patients taking ARICEPT 23 mg/day versus patients taking ARICEPT 10 mg/day. Some people may feel tired or may have loss of appetite. If they persist, please talk to the doctor.

Indication

ARICEPT (donepezil HCl) is a prescription medicine to treat mild Alzheimer's disease (up to 10 mg/day) and moderate to severe Alzheimer's disease (up to 23 mg/day).

Before starting on ARICEPT 23 mg/day, patients should be on ARICEPT 10 mg/day for at least 3 months. The starting dose of ARICEPT is 5 mg/day and can be increased to 10 mg/day after 4-6 weeks. Please take ARICEPT as prescribed by the doctor.

Full Prescribing Information Button

Get Valuable Information

Sign up for:

  • ARICEPT information
  • Helpful caregiving tips
  • Alzheimer’s information

Just complete the fields below and click “Submit.” We’ll send the information as soon as it becomes available.

All fields are required.

  • Have you or a loved one been diagnosed with Alzheimer’s?

  • Are you or your loved one currently taking ARICEPT?

  • First Name:

    Last Name:

  • Address Line 1:

    Address Line 2:

    City:

    State:

    ZIP Code:

    E-mail Address:

  • Please let us know how you prefer to receive information:

  • I am 18 or older

The ARICEPT Patient Assistance Program can help qualified indigent and uninsured patients obtain ARICEPT at no cost. Assistance is also available to Medicare Part D-insured patients who are in the coverage gap or donut hole. To learn more and receive an application for assistance, please contact us Monday—Friday from 9 AM to 6 PM ET at: Phone: 1-800-226-2072, Fax: 1-800-226-2059.

This site is intended for residents of the United States only. The products discussed herein may have different product labeling in different countries.

ARICEPT® is a registered trademark of Eisai Co., Ltd.
© 2008-2010 Eisai Inc. and Pfizer Inc. All rights reserved. AAR00195-A

Important Safety Information  |   Prescribing and Patient Info  |   Legal Notices and Disclaimers  |   Privacy Policy